Previous close | 0.4500 |
Open | 0.4500 |
Bid | 0.0000 |
Ask | 0.6500 |
Strike | 10.00 |
Expiry date | 2024-07-19 |
Day's range | 0.4500 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 465 |
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector GrowthALACHUA, Fla. and TAMPA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will celebrate the opening of its Axogen Processing Center (APC) with leaders of the Ohio community on June 12, 2024. APC is designed to process Avance Nerve Graft®, a regenerative peripheral nerve scaf
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.